This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Frederick Appelbaum, A World Expert In Blood Cancers, Named Deputy Director Of Fred Hutchinson Cancer Research Center

"While at the NCI I was fortunate enough to publish several papers and will never forget the day when the phone rang and it was Don Thomas on the other end, asking me if I would possibly be interested in coming to Seattle to work with him," he said.

Appelbaum joined Thomas and colleagues at the Hutch in the late '70s and led the trials that defined the role of transplantation in the treatment of acute myeloid leukemia (AML), myelodysplasia and malignant lymphoma. He continues to study the biology of AML and mechanisms of drug resistance.

A national leader in the conduct of clinical trials

Beyond his own research, Appelbaum has been a national leader in the conduct of clinical trials. In 1980, as part of the Southwest Oncology Group, a cancer research cooperative, he formed the first multi-center bone marrow transplant clinical trials group. This concept eventually evolved into the federally funded Bone Marrow Transplant Clinical Trials Network, of which he is chair-elect. For more than 20 years Appelbaum served as chair of the SWOG Leukemia Committee, which designs and conducts clinical trials for leukemia.

Appelbaum is past chair of the NCI Board of Scientific Advisors and has served on the boards of a number of scientific societies, including the American Society of Hematology, the American Society of Clinical Oncology (ASCO), the American Association of Cancer Research (AACR) and the American Society for Blood and Marrow Transplantation (ASBMT). 

Currently he serves on the NCI Leukemia Steering Committee and on the advisory committees of many organizations, including Memorial Sloan-Kettering Cancer Center, Yale Cancer Center, Johns Hopkins Cancer Center, University of Pennsylvania Cancer Center, University of Michigan Cancer Center, University of California San Francisco Cancer Center and the AACR Stand Up to Cancer Scientific Advisory Committee.

His honors and awards include election to the Alpha Omega Alpha medical honor society, the ASCO Statesman Award and the ASBMT's E.D. Thomas Lecture and Award.

3 of 4

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,880.36 -31.75 -0.19%
S&P 500 1,970.07 +0.12 0.01%
NASDAQ 4,462.9020 +20.2040 0.45%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs